
51 - 200 employees
💰 $28.7M Series C on 2017-10
Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs. The company’s first product is the Lumicell Direct Visualization System, designed to provide real-time illumination of cancerous tissue within the breast cavity during the initial lumpectomy, potentially reducing repeat surgeries. Lumicell’s proprietary, pan-oncologic optical imaging agent is also being explored across a wide variety of solid tumor indications. The company aims to enhance the standard of care treatment by guiding the resection of additional cancer that may have otherwise been left behind.
🔥 16 minutes ago
51 - 200
Clinical Applications Specialist providing clinical support and training for LumiSystem in the Northeast. Engaging with healthcare professionals to ensure successful integration and customer satisfaction.